ATE308497T1 - Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchen - Google Patents

Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchen

Info

Publication number
ATE308497T1
ATE308497T1 AT97920694T AT97920694T ATE308497T1 AT E308497 T1 ATE308497 T1 AT E308497T1 AT 97920694 T AT97920694 T AT 97920694T AT 97920694 T AT97920694 T AT 97920694T AT E308497 T1 ATE308497 T1 AT E308497T1
Authority
AT
Austria
Prior art keywords
pct
cyclin
interaction
estrogen receptor
trials
Prior art date
Application number
AT97920694T
Other languages
English (en)
Inventor
Rene Bernards
Rob J A M Michalides
Renate M L Zwijsen
Original Assignee
Prolifix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prolifix Ltd filed Critical Prolifix Ltd
Application granted granted Critical
Publication of ATE308497T1 publication Critical patent/ATE308497T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
AT97920694T 1996-04-19 1997-04-16 Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchen ATE308497T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9608143.5A GB9608143D0 (en) 1996-04-19 1996-04-19 Assay
PCT/EP1997/001888 WO1997040378A1 (en) 1996-04-19 1997-04-16 Interaction of cyclin d1 and estrogen receptor and its use in assays

Publications (1)

Publication Number Publication Date
ATE308497T1 true ATE308497T1 (de) 2001-11-15

Family

ID=10792355

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920694T ATE308497T1 (de) 1996-04-19 1997-04-16 Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchen

Country Status (10)

Country Link
US (1) US6033843A (de)
EP (1) EP0898708B1 (de)
JP (1) JP2000508777A (de)
AT (1) ATE308497T1 (de)
AU (1) AU2698197A (de)
CA (1) CA2249396A1 (de)
DE (1) DE69708081T2 (de)
DK (1) DK0898708T3 (de)
GB (1) GB9608143D0 (de)
WO (1) WO1997040378A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018124A1 (en) * 1997-10-07 1999-04-15 Merck & Co., Inc. Assays for nuclear receptor ligands using fret
AU2533499A (en) 1998-02-12 1999-08-30 Prolifix Limited Interaction between cyclin d1 and steroid receptor co-activators and uses thereof in assays
US6210924B1 (en) * 1998-08-11 2001-04-03 Amgen Inc. Overexpressing cyclin D 1 in a eukaryotic cell line
AU2001230606A1 (en) * 2000-02-10 2001-08-20 Chugai Seiyaku Kabushiki Kaisha Method of screening antiandrogen agent
EP1167975B1 (de) * 2000-06-22 2009-10-07 Universite Paris Descartes Zusammensetzungen und Methoden zum Nachweis, Behandeln oder Vorhersagen der Antwort von Brust Tumorzellen auf eine Endocrin-Therapie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010307A1 (en) * 1992-10-29 1994-05-11 Medical Research Council Transcription factor dp-1

Also Published As

Publication number Publication date
DE69708081T2 (de) 2002-07-04
AU2698197A (en) 1997-11-12
EP0898708A1 (de) 1999-03-03
DE69708081D1 (de) 2001-12-13
JP2000508777A (ja) 2000-07-11
WO1997040378A1 (en) 1997-10-30
CA2249396A1 (en) 1997-10-30
US6033843A (en) 2000-03-07
EP0898708B1 (de) 2001-11-07
GB9608143D0 (en) 1996-06-26
DK0898708T3 (da) 2002-03-04

Similar Documents

Publication Publication Date Title
IL117425A0 (en) Receptor activation by gas6
BR9811956A (pt) Naftiridinonas para a inibição de proteìna tirosina cinase e de proliferação celular mediada por cinase de ciclo de célula
ATE296799T1 (de) P38-inhibitoren
TR200200662T2 (tr) Alzheimer hastalığı sekretazı
TR200003513T2 (tr) Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları
ATE517125T1 (de) ANTIKÖRPER GEGEN ßDEATH RECEPTOR 4ß (DR4) UND DEREN VERWENDUNGEN
BR0308339A (pt) Indazóis substituìdos com uma atividade anticancerosa
DE60131430D1 (de) Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
Kanafi et al. Influence of hypoxia, high glucose, and low serum on the growth kinetics of mesenchymal stem cells from deciduous and permanent teeth
AR018023A1 (es) Procedimiento para la fabricacion de polipeptidos con glicosilacion apropiada
DE69825066D1 (de) Veränderte proteinkinasen, die modifizierte nukleotidtriphosphat substrate verwenden können
ATE309378T1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
DK0701604T3 (da) Immortalisering af dendritiske celler med V-myc-onkogenet
DE69708081D1 (de) Interaktion von cyclin d1 mit estrogenrezeptor und entsprechende anwendungen in versuchen
ATE262537T1 (de) Proliferationsinhibitor von endothellzellen und dessen verwendung
TR200201459T2 (tr) Okzkarbazepin içeren süspansiyon
Smadja et al. PAR‐1 activation has different effects on the angiogenic activity of endothelial progenitor cells derived from human adult and cord blood
ATE274351T1 (de) Verwendung von isolierten domänen des type-iv- kollagens zur änderung der zell- und gewebewechselwirkung
ATE309332T1 (de) Unsterbliche retinalzellinien und deren anwendungen
DE59508100D1 (de) Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander
Lefor et al. Enhanced cytolytic activity of tumor infiltrating lymphocytes (TILs) derived from an ICAM-1 transfected tumor in a murine model
DE69333962D1 (de) Modifizierte zellen auf der basis des betain-katabolismus, herstellung und verwendung insbesondere zur herstellung von metaboliten oder enzymen
ATE417926T1 (de) Zusammensetzungen zur modulierung der länge von telomeren
TR200003695T2 (tr) Anjiyostatin bağlayıcı protein.
Van Kooyk et al. Signalling and adhesive properties of the integrin leucocyte function-associated antigen I (LFA-I)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties